A detailed history of Consolidated Portfolio Review Corp transactions in Metlife Inc stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 4,174 shares of MET stock, worth $345,398. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,174
Previous 4,127 1.14%
Holding current value
$345,398
Previous $290 Million 18.85%
% of portfolio
0.08%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$67.96 - $82.48 $3,194 - $3,876
47 Added 1.14%
4,174 $344 Million
Q2 2024

Jul 31, 2024

BUY
$68.55 - $74.22 $282,905 - $306,305
4,127 New
4,127 $290 Million
Q3 2023

Nov 13, 2023

BUY
$56.71 - $66.36 $248,049 - $290,258
4,374 New
4,374 $275 Million

Others Institutions Holding MET

About METLIFE INC


  • Ticker MET
  • Exchange NYSE
  • Sector Financial Services
  • Industry Insurance—Life
  • Shares Outstandng 797,614,016
  • Market Cap $66B
  • Description
  • MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...
More about MET
Track This Portfolio

Track Consolidated Portfolio Review Corp Portfolio

Follow Consolidated Portfolio Review Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Portfolio Review Corp with notifications on news.